A Safety and Tolerability Study of Denufosol in 2-4 Year Olds

Clinical trial NCT01181622 · COMPLETED

Trial details

NCT number: NCT01181622
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2010-08-01
Primary completion: 2010-10-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.